Sachan Swati, Dhama Kuldeep, Latheef Shyma K, Samad Hari Abdul, Mariappan Asok Kumar, Munuswamy Palanivelu, Singh Rajendra, Singh Karam Pal, Malik Yashpal Singh, Singh Raj Kumar
Immunology Section, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly 243 122, Uttar Pradesh, India.
Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly 243 122, Uttar Pradesh, India.
Vaccines (Basel). 2019 Sep 4;7(3):106. doi: 10.3390/vaccines7030106.
Infectious bursal disease (IBD), caused by infectious bursal disease virus (IBDV), is characterized by severe immunosuppression in young chicks of 3 to 6 week age group. Although vaccines are available to prevent IBD, outbreaks of disease are still noticed in the field among vaccinated flocks. Further, the birds surviving IBD become susceptible to secondary infections caused by various viral and bacterial agents. This study assessed the immunoprophylactic potential of Cytosine-guanosinedeoxynucleotide (CpG) oligodeoxynucleotides (ODN) and stem aqueous extract in the specific pathogen free (SPF) chicks, experimentally infected with very virulent IBDV (vvIBDV). Both of these agents (CpG ODN and herbal extract) showed significant increase in the IFN-γ, IL-2, IL-4, and IL-1 levels in the peripheral blood mononuclear cells (PBMCs) ( < 0.05) of chickens in the treatment groups following IBD infection.Further we found significant reduction in mortality rate in vvIBDV infected chicks treated with either, or in combination, compared with the birds of control group. Additionally, the adjuvant or immune enhancing potential of these two immunomodulatory agents with the commercially available IBDV vaccine was determined in chicks. The augmentation of vaccine response in terms of an enhanced antibody titer after vaccination, along with either or a combination of the two agents was noticed. The findings provide a way forward to counter the menace of IBDV in the poultry sector through use of these herbal or synthetic immunomodulatory supplements.
传染性法氏囊病(IBD)由传染性法氏囊病病毒(IBDV)引起,其特征是3至6周龄的幼雏出现严重免疫抑制。尽管有疫苗可预防IBD,但在接种疫苗的鸡群中仍有疾病暴发。此外,从IBD中存活下来的鸡易受各种病毒和细菌病原体引起的继发感染。本研究评估了胞嘧啶 - 鸟嘌呤脱氧核苷酸(CpG)寡脱氧核苷酸(ODN)和茎水提取物在经超强毒力IBDV(vvIBDV)实验感染的无特定病原体(SPF)雏鸡中的免疫预防潜力。在IBD感染后,这两种制剂(CpG ODN和草药提取物)在治疗组鸡的外周血单核细胞(PBMC)中均显示出IFN-γ、IL-2、IL-4和IL-1水平显著升高(P<0.05)。此外,我们发现,与对照组鸡相比,用其中任何一种或两者联合处理的vvIBDV感染雏鸡的死亡率显著降低。此外,还在雏鸡中测定了这两种免疫调节剂与市售IBDV疫苗联合使用时的佐剂或免疫增强潜力。接种疫苗后,观察到抗体滴度提高,以及使用其中任何一种或两者联合使用时疫苗反应增强。这些发现为通过使用这些草药或合成免疫调节补充剂应对家禽业IBDV威胁提供了一条途径。